Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Laser test could objectively measure nerve pain for first time

NCT ID NCT06030297

First seen Apr 23, 2026 · Last updated Jun 22, 2026 · Updated 11 times

Summary

This study tested whether a diode laser can act as a biomarker to measure neuropathic pain in people with peripheral neuropathy. Researchers compared pain responses to a lidocaine patch versus a placebo patch in 75 participants. The goal was to see if the laser test could distinguish between real pain relief and placebo effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Stanford University

    Palo Alto, California, 94305, United States

  • University of Utah

    Salt Lake City, Utah, 84132, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

lidocaine patch (ZTlido 1.8%)

What this could lead to

If successful, this could provide a reliable way to objectively measure nerve pain, helping doctors diagnose and treat it more effectively.

What could go wrong

This is a small, early-stage study focused on measurement, not treatment. The laser test may not prove accurate enough for widespread use.

Conditions

The condition(s) this trial relates to.

neuralgia peripheral nervous system disorder peripheral neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.